
Zopenta 6.25mg Tablet ER
Marketer
Alkem Laboratories Ltd
Salt Composition
Zolpidem (6.25mg)
Overview Zopenta 6.25mg Tablet ER
Somnia-6.25mg Extended-Release tablets provide short-term insomnia relief. They shorten sleep onset, reduce nighttime awakenings, and promote sustained sleep. Take Somnia-6.25mg ER on an empty stomach, ideally before bedtime, consistently at the same time daily for consistent blood levels. Follow your doctor's prescribed dosage and duration; this medication can be habit-forming and should not be discontinued abruptly without medical consultation. Potential side effects include, but aren't limited to: memory impairment, visual or auditory distortions, restlessness, headache, dizziness, diarrhea, nausea, vomiting, backache, fatigue, abdominal discomfort, blurred vision, and depressive symptoms. These are typically transient. Report persistent or bothersome effects to your physician. Somnia-6.25mg ER may cause drowsiness and impaired coordination; avoid driving or mentally demanding tasks until its effects are known. Refrain from alcohol consumption while using this medication. Report any unusual mood shifts, worsening depression, hallucinations, or suicidal ideation immediately. Always inform your doctor of all other medications before starting Somnia-6.25mg ER. Individuals with liver or kidney disease should consult their doctor prior to use. Smoking and alcohol should be avoided during treatment. This medication is contraindicated for pregnant and breastfeeding women; consult your doctor if necessary.
Primary Ingredients of Zopenta 6.25mg Tablet ER
No information provided. Unable to rephrase.
Uses of Zopenta 6.25mg Tablet ER
Managing Sleep Difficulties
Major Benefits of Zopenta 6.25mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Zopenta 6.25mg Extended-Release Tablet on an empty stomach.
Common Side effects of Zopenta 6.25mg Tablet ER:
- Dizziness
- Sleepiness
- Headache
- Nausea
- Stomach pain
- Memory loss
- Vertigo
- Vomiting
- Back pain
- Agitation
- Double vision
- Depression
How to use Zopenta 6.25mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Administer Zopenta 6.25mg Extended-Release Tablet on an empty stomach.
How Zopenta 6.25mg Tablet ER works:
Eszopiclone 6.25mg extended-release tablets are classified as non-benzodiazepine sleep aids. This medication possesses sedative, hypnotic, and anticonvulsive effects, controlling seizures. Its mechanism involves interaction with the GABAA receptor chloride channel complex, a neurotransmitter receptor, thereby reducing neuronal activity in the brain and promoting sleep onset.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Zopenta 6.25mg Extended-Release tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The extended-release Zopenta 6.25mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Zopenta 6.25mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Extended-release Zopenta 6.25mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Extended-release Zopenta 6.25mg tablets are considered safe for use by individuals with kidney impairment; no dosage modification is necessary. Nevertheless, disclosure of any kidney condition to your physician is advisable.
LiverCAUTION
Patients with liver impairment should use Zopenta 6.25mg Extended-Release Tablets cautiously. Dosage modifications may be necessary for Zopenta 6.25mg Extended-Release Tablets. Physician consultation is advised. A reduced initial dose of Zopenta 6.25mg Extended-Release Tablets is typically prescribed for individuals with mild to moderate hepatic dysfunction; its use is contraindicated in those with severe liver disease.
What if you forget to take Zopenta 6.25mg Tablet ER :
Omit any missed Zopenta 6.25mg Extended-Release Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Zopenta 6.25mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Imidazopyridine compound |
| Developing Habits | Affirmative. |
| Type of Treatment | Neuroscience of the Central Nervous System |
| Action Category | Non-benzodiazepine sleeping pills (Z-drugs) |
